|
|
7601 Northland Drive, Suite 170
Brooklyn Park, MN 55428 USA
phone:(866) 709-4030
fax:(763) 463-4606
|
|
| Symbol |
Private |
| Founded |
1999 |
| Employees |
|
|
|
| www.chfsolutions.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. |
|
| Management |
| David B. Springer, Chief Executive Officer and President; Patrick Wethington, Vice President of Global Sales and Marketing; John OMahony, Vice President of Operations, R&D, RA and QA; Ronald M. Nelson, Chief Financial Officer; John R. Wigneswaran MD, Senior Medical Director, Medical Affairs |
| |
|
|
| |
|
| Keywords |
| aquapheresis, aquadex, diuretics, cardiology, ultrafitration |
|
|
|
| Description |
|
CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system.
Fluid overload is failure to eliminate excess fluid, primarily salt and water from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid-overload, congestive heart failure (CHF) is a leading cause.
Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid-overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patients blood at a controlled rate and the system does so in a highly controlled and effective way. |
|
| Products / Services |
CHF Solutions' Aquadex FlexFlow is a technologically sophisticated, yet easy-to-use mechanical pump/ultrafiltration system that can remove up to 500mL/hr of excess fluid from the blood of fluid-overloaded patients. It provides physicians with the ability to precisely tailor the amount and rate of fluid removal per patient, resulting in a gradual reduction of fluid with no clinically significant effect on electrolyte balance or other hemodynamics.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members